Chief People Officer · Enfusion, Inc. (ENFN)

Bronwen Bastone

FY2022 is the first fiscal year CompBrief holds for Bronwen Bastone as a named executive officer of Enfusion; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,864,846

Salary $450,000Stock awards $1,199,996

1st of 4 named executive officers at Enfusion by FY2022 total.

4 named officers on file for Enfusion, FY2022

Bronwen Bastone’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Enfusion’s whole pay program stands against its peers

  • Enfusion’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ENFN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 1, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Bronwen Bastone’s full pay file as a PDF — free

More than this page: up to 10 years of Bronwen’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Bronwen Bastone compensation by year

Enfusion Summary Compensation Table · the one fiscal year held
In US dollars, as Enfusion reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022
Salary$450,000
Bonus$0
Stock awards$1,199,996
Option awards$98,600
Non-equity incentive$114,000
Pension and deferred compensation$0
All other$2,250
Total$1,864,846

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Enfusion, Inc. DEF 14A filed May 1, 2023, accession 0001558370-23-007435, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Enfusion, Inc. filed document, accession 0001558370-23-007435. Every figure is read from that document and cited to the page and table it appears in. Filed May 1, 2023.

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU80,000$773,600—
RSU26,470$255,965—
PSU11,765$113,768—
PSU11,765$113,768—
PSU11,764$113,758—
RSU6,339$61,298—
Option10,000—$9.86

Per the Outstanding Equity Awards at Fiscal Year-End table in Enfusion, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

36 Form 4 lines since the FY2022 proxy (filed May 1, 2023)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2025-04-21Disposition to the issuer—15,864—197,187
2025-04-21Disposition to the issuer—35,294—0
2025-04-21Disposition to the issuer derivative—10,000—0
2025-04-21Disposition to the issuer—161,893—35,294
2025-03-05Sale—3,126$11.38221,875
2025-03-03Sale—2,064$11.48225,001
2025-02-26Grant or award—5,724$0.00227,065
2025-02-26Grant or award—26,456$0.00221,341

The 8 most recent of 36 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Enfusion’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Bronwen Bastone · this pageChief People Officer$1,864,846
Bradley HerringChief Financial Officer$1,793,045
Oleg MovchanChief Executive Officer and Director$1,657,048
Thomas KimFormer Chief Executive Officer$1,261,230

The full Enfusion compensation record

free company brief

This page is one person within Enfusion's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Enfusion's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Bronwen Bastone's compensation dossier · One-time report. No refunds.